Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Is Baxter International an Underrated Healthcare Investment Play?


Baxter International (NYSE: BAX) was a dividend stock, but it's no longer one. That's because the dividend was just cut from $0.17 per share per quarter to a token penny. dividend lovers will want to skip on this stock, but turnaround investors and those with a value bias may find it worthy of a deep dive.

Baxter makes medical products like surgical sealants and hospital beds. What it makes may not be sexy -- say, like Intuitive Surgical's da Vinci surgical robot -- but the healthcare industry needs what Baxter sells to operate. That's the long-term story that matters most. Indeed, the aging of the baby boomer generation is likely to lead to increased demand for healthcare. Which, in turn, means increased demand for Baxter's perhaps mundane products.

Image source: Getty Images.

Continue reading


Source Fool.com

Vinci S.A. Stock

€134.95
1.090%
There is an upward development for Vinci S.A. compared to yesterday, with an increase of €1.45 (1.090%).
Currently there is a rather positive sentiment for Vinci S.A. with 3 Buy predictions and 0 Sell predictions.
As a result the target price of 140 € shows a slightly positive potential of 3.74% compared to the current price of 134.95 € for Vinci S.A..
Like: 0
BAX
Share

Comments